David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
1051
DELISTED
QVC Group Inc Series A
QVCGA
| $14.2M | 0.02% |
174,629
+50,241
| +40% | +$5.12M |
|
1052
Xenon Pharmaceuticals
XENE
$5.86B
| $14.2M | 0.02% |
360,421
-49,142
| -12% | -$1.79M |
|
1053
Canadian Solar
CSIQ
$972M
| $14.1M | 0.02% |
457,686
+105,607
| +30% | +$3.55M |
|
1054
Honeywell
HON
$68.1B
| $14M | 0.02% |
69,418
-700,208
| -91% | -$134M |
|
|
NSTG
1055
DELISTED
NanoString Technologies, Inc.
NSTG
| $14M | 0.02% |
1,754,431
+959,230
| +121% | +$8.32M |
|
1056
Huazhu Hotels Group
HTHT
$15B
| $13.9M | 0.02% |
328,418
-92,689
| -22% | -$3.35M |
|
1057
Baker Hughes
BKR
$61.5B
| $13.9M | 0.02% |
471,641
-1,202,905
| -72% | -$33.2M |
|
1058
United Airlines
UAL
$36.9B
| $13.9M | 0.02% |
369,190
-455,600
| -55% | -$18.5M |
|
1059
Synaptics
SYNA
$3.66B
| $13.9M | 0.02% |
146,037
+41,430
| +40% | +$3.98M |
|
1060
Asana
ASAN
$2.25B
| $13.9M | 0.02% |
1,008,941
-477,818
| -32% | -$8.67M |
|
1061
Resideo Technologies
REZI
$2.93B
| $13.9M | 0.02% |
844,147
-205,094
| -20% | -$3.72M |
|
|
CTEV
1062
Claritev Corp
CTEV
$620M
| $13.9M | 0.02% |
301,738
+184,450
| +157% | +$14.7M |
|
1063
Enviri
NVRI
$595M
| $13.9M | 0.02% |
2,203,175
+472,073
| +27% | +$2.81M |
|
1064
Rollins
ROL
$17.9B
| $13.8M | 0.02% |
378,750
+318,248
| +526% | +$12.4M |
|
1065
3D Systems Corp
DDD
$518M
| $13.8M | 0.02% |
1,867,150
-96,480
| -5% | -$846K |
|
1066
Parsons
PSN
$5.21B
| $13.8M | 0.02% |
298,207
+237,527
| +391% | +$10.9M |
|
1067
CDW
CDW
$16.6B
| $13.8M | 0.02% |
77,127
-39,885
| -34% | -$7.01M |
|
1068
Mobileye
MBLY
$7.35B
| $13.7M | 0.02% |
+392,041
| New | +$11.9M |
|
1069
PUT
Nutrien
NTR
$35.5B
| $13.7M | 0.02% |
188,100
-32,500
| -15% | -$2.57M |
|
1070
Acuity Brands
AYI
$10.1B
| $13.7M | 0.02% |
82,912
-24,931
| -23% | -$4.43M |
|
1071
Merit Medical Systems
MMSI
$5.39B
| $13.7M | 0.02% |
194,158
-29,824
| -13% | -$1.99M |
|
1072
CALL
Affirm
AFRM
$25.7B
| $13.7M | 0.02% |
1,417,700
+603,700
| +74% | +$9.1M |
|
|
MRSN
1073
DELISTED
Mersana Therapeutics
MRSN
| $13.7M | 0.02% |
93,438
-11,531
| -11% | -$1.95M |
|
|
POW
1074
DELISTED
Powered Brands Class A Ordinary Shares
POW
| $13.7M | 0.02% |
1,350,959
+403,669
| +43% | +$4.05M |
|
1075
Paylocity
PCTY
$8.09B
| $13.7M | 0.02% |
70,278
+48,647
| +225% | +$10.4M |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.